e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rate of progression of lung function impairment in α1-antitrypsin deficiency
Dawkins P. A., Dawkins C. L., Wood A. M., Nightingale P. G., Stockley J. A., Stockley R. A.
Source:
Eur Respir J 2009; 33: 1338-1344
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dawkins P. A., Dawkins C. L., Wood A. M., Nightingale P. G., Stockley J. A., Stockley R. A.. Rate of progression of lung function impairment in α1-antitrypsin deficiency. Eur Respir J 2009; 33: 1338-1344
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002
Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001
The association between serum osmolality and lung function among adults
Source: Eur Respir J 2008; 32: 98-104
Year: 2008
Desmosin as a marker for tissue injury in COPD
Source: Annual Congress 2007 - α
1
-Antitrypsin deficiency: molecular and clinical news
Year: 2007
Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
The relationship between radiologic findings and lung function impairment in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012
PP310 – Association of testosterone with lung function in patients with chronic obstructive lung disease
Source: ERS Lung Science Conference 2021
Year: 2021
Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Association between endothelial function and pulmonary function in patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Effects of severity of chronic obstructive pulmonary disease on thyroid function
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease.
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Effects of lung development on pulmonary function tests: from early life to chronic respiratory disease
Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept